We are live on ! Find out more
NB

Norinchukin Bank Portfolio holdings

AUM $8.57B
1-Year Est. Return 20.17%
This Fund
S&P 500
This Quarter Est. Return
+8.13%
1 Year Est. Return
+20.17%
3 Year Est. Return
+71.71%
5 Year Est. Return
+89.7%
10 Year Est. Return
+317.21%
AUM
$6.92B
AUM Growth
-$345M
Cap. Flow
-$882M
Cap. Flow %
-12.75%
Top 10 Hldgs %
49.31%
Holding
542
New
6
Increased
189
Reduced
340
Closed
3

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$41.7M
2
ROL icon
Rollins
ROL
+$9.74M
3
DIS icon
Walt Disney
DIS
+$3.74M
4
MSFT icon
Microsoft
MSFT
+$3.73M
5
ECL icon
Ecolab
ECL
+$2.42M

Sector Composition

Rank Sector Weight
1 Technology 14.57%
2 Healthcare 8.41%
3 Industrials 7.15%
4 Consumer Discretionary 6.83%
5 Communication Services 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FISV
126
Fiserv Inc
FISV
$27.9B
$6.09M 0.09%
56,943
+2,515
+5% +$292K
ADSK icon
127
Autodesk
ADSK
$52.6B
$6.05M 0.09%
20,736
+291
+1% +$83K
FDX icon
128
FedEx
FDX
$75.4B
$6.02M 0.09%
20,194
-91
-0.4% -$27K
ADI icon
129
Analog Devices
ADI
$190B
$5.98M 0.09%
34,758
+410
+1% +$65.7K
WFC icon
130
Wells Fargo
WFC
$264B
$5.71M 0.08%
125,955
-1,662
-1% -$74.2K
DOW icon
131
Dow Inc
DOW
$21.2B
$5.63M 0.08%
88,924
+5,183
+6% +$342K
REGN icon
132
Regeneron Pharmaceuticals
REGN
$80.8B
$5.52M 0.08%
9,886
+130
+1% +$65.9K
NSC icon
133
Norfolk Southern
NSC
$75.1B
$5.5M 0.08%
20,706
-247
-1% -$68.2K
NXPI icon
134
NXP Semiconductors
NXPI
$60.4B
$5.35M 0.08%
25,987
+240
+0.9% +$48.1K
EW icon
135
Edwards Lifesciences
EW
$51.7B
$5.33M 0.08%
51,437
-464
-0.9% -$43.7K
SO icon
136
Southern Company
SO
$107B
$5.3M 0.08%
87,595
-310
-0.4% -$19.8K
APD icon
137
Air Products & Chemicals
APD
$67.6B
$5.27M 0.08%
18,310
-85
-0.5% -$25K
TRV icon
138
Travelers Companies
TRV
$80.2B
$5.21M 0.08%
34,780
+5,240
+18% +$813K
WM icon
139
Waste Management
WM
$91B
$5.11M 0.07%
36,435
+4,075
+13% +$563K
IDXX icon
140
Idexx Laboratories
IDXX
$46.2B
$5.08M 0.07%
8,048
+112
+1% +$61.8K
WBA
141
DELISTED
Walgreens Boots Alliance
WBA
$5.07M 0.07%
96,423
+6,576
+7% +$354K
BSX icon
142
Boston Scientific
BSX
$71.5B
$5.03M 0.07%
117,571
-305
-0.3% -$12.8K
VRTX icon
143
Vertex Pharmaceuticals
VRTX
$126B
$4.92M 0.07%
24,395
+217
+0.9% +$45.4K
BIIB icon
144
Biogen
BIIB
$30.7B
$4.91M 0.07%
14,187
+26
+0.2% +$7.88K
D icon
145
Dominion Energy
D
$59.3B
$4.91M 0.07%
66,728
-283
-0.4% -$21.8K
ETN icon
146
Eaton
ETN
$174B
$4.89M 0.07%
32,972
-193
-0.6% -$27.8K
F icon
147
Ford
F
$55.7B
$4.82M 0.07%
324,422
-624
-0.2% -$8.29K
HUM icon
148
Humana
HUM
$46.2B
$4.72M 0.07%
10,669
-51
-0.5% -$22.3K
KLAC icon
149
KLA
KLAC
$259B
$4.68M 0.07%
144,450
+890
+0.6% +$28.5K
PSA icon
150
Public Storage
PSA
$61.3B
$4.6M 0.07%
15,286
+119
+0.8% +$33.4K

Similar funds

Norinchukin Bank's Q2 2021 Portfolio in Review

As of Q2 2021, Norinchukin Bank held 542 positions worth $6.92B, down 4.7% from $7.26B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Norinchukin Bank withdrew a net $882M in Q2 2021, closing 3 positions and reducing 340 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $1.34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Norinchukin Bank opened a new position in Fair Isaac worth $1.83M.

  • Norinchukin Bank's largest Q2 2021 buy was Fair Isaac: 3,650 shares worth $1.83M.
  • Norinchukin Bank added most to Invesco QQQ Trust in Q2 2021, an estimated $41.7M increase.
  • Norinchukin Bank's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $540M.
  • Norinchukin Bank fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.34M.
  • Norinchukin Bank's ten largest holdings make up 49% of its $6.92B portfolio in Q2 2021.
  • Norinchukin Bank opened 6 new positions and closed 3 in Q2 2021.
  • Norinchukin Bank's portfolio value fell 4.7% quarter-over-quarter to $6.92B.

Based on Norinchukin Bank's 13F filing for Q2 2021, filed 11 Aug 2021.